NIH, National Cancer Institute, Division of Cancer Treatment and Diagnosis (DCTD) NIH - National Institutes of Health National Cancer Institute DCTD - Division of Cancer Treatment and Diagnosis

Potential interferences from blood collection tubes in mass spectrometric analyses of serum polypeptides.

Author(s): Drake SK, Bowen RA, Remaley AT, Hortin GL

Publication: Clin Chem, 2004, Vol. 50, Page 2398-401

PubMed ID: 15563493 PubMed Review Paper? No

Purpose of Paper

The purpose of this paper was to determine whether different types of blood collection tubes shed exogenous molecules capable of interfering with MALDI-TOF mass spectrometry peptide analysis.

Conclusion of Paper

The majority of serum collection tubes tested shed polymers that can be detected in the 1000-3000 m/z range, potentially compromising the analysis of low-molecular weight peptides through mass spectrometry; while the majority of plasma collection tubes tested did not generated exogenous mass spectrometry peaks. The authors suggest collection tube type should be standardized and screened for interference before analysis.

Studies

  1. Study Purpose

    The purpose of this study was to determine whether different types of blood collection tubes shed exogenous molecules capable of interfering with MALDI-TOF mass spectrometry peptide analysis. Both serum and plasma collection tubes were assessed by incubating saline in respective tubes at room temperature for 4 hours; biospecimens were not directly investigated.

    Summary of Findings:

    With the exception of no-additive glass tubes all serum collection tubes generated a series of MALDI-TOF mass spectrometry peaks within the m/z range of 1000 to 3000; tubes from two different manufacturers produced similar results. Conversely, the majority of plasma collection tubes investigated did not yield peptide peaks suggesting minimal interference, including EDTA-containing plasma tubes, no-additive glass tubes with a glycerol coated stopper, and tubes containing citrate or heparin additives. Research-use plasma separator tubes containing protein stabilizing additives generated several peaks within the m/z range of 1050-6880.

    Biospecimens
    Preservative Types
    • None (Fresh)
    Diagnoses:
    • Not specified
    Platform:
    AnalyteTechnology Platform
    Peptide MALDI-TOF MS
    Pre-analytical Factors:
    ClassificationPre-analytical FactorValue(s)
    Biospecimen Acquisition Type of collection container/solution 10 ml Vacutainer Clot Activator Plus Plastic
    7 ml Vacutainer SST Gel and Clot Activator
    3.5 ml Vacutainer SST Gel and Clot Activator
    8.5 ml Plus Plastic EDTA separator
    2.5 ml Vacuette Z serum separator (clot activator)
    4 ml Vacuette Z serum separator (clot activator)
    8 ml Vacuette Z serum separator (clot activator)
    10 x 65 mm Glass Vacutainer
    6 ml Vacutainer Plus sodium heparin
    4.5 ml Vacutainer buffered sodium citrate
    3 ml Vacutainer Plus 5.4 mg K2EDTA

You Recently Viewed  

News and Announcements

  • Just Published!

  • April 24, 2024: Biobanking for Precision Medicine Seminar

  • Most Popular SOPs in March 2024

  • More...